Dezhi Li

580 total citations
25 papers, 425 citations indexed

About

Dezhi Li is a scholar working on Molecular Biology, Cancer Research and Endocrinology. According to data from OpenAlex, Dezhi Li has authored 25 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cancer Research and 3 papers in Endocrinology. Recurrent topics in Dezhi Li's work include Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (3 papers). Dezhi Li is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (3 papers). Dezhi Li collaborates with scholars based in China, France and India. Dezhi Li's co-authors include Xiaofeng Wang, Wenfeng Chu, Wei Zheng, Dan Zhao, Dongyang Xu, Dongmei Wu, Zhiqiang Huang, Qing Liu, Yaqin Li and Kun Liu and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Frontiers in Microbiology.

In The Last Decade

Dezhi Li

25 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dezhi Li China 13 259 102 62 56 50 25 425
Yusheng Li China 11 240 0.9× 102 1.0× 65 1.0× 66 1.2× 39 0.8× 25 452
Yufeng Liu China 13 241 0.9× 97 1.0× 33 0.5× 58 1.0× 36 0.7× 38 465
Kaikai Yu China 10 229 0.9× 80 0.8× 76 1.2× 111 2.0× 45 0.9× 22 440
Fuli Shi China 12 262 1.0× 52 0.5× 35 0.6× 83 1.5× 42 0.8× 20 421
Wanwei Zheng China 10 221 0.9× 98 1.0× 39 0.6× 62 1.1× 37 0.7× 20 406
Yixiu Wang China 13 215 0.8× 138 1.4× 108 1.7× 30 0.5× 49 1.0× 31 468
Mohd Omar Faruk Sikder United States 7 246 0.9× 153 1.5× 44 0.7× 98 1.8× 68 1.4× 14 428

Countries citing papers authored by Dezhi Li

Since Specialization
Citations

This map shows the geographic impact of Dezhi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dezhi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dezhi Li more than expected).

Fields of papers citing papers by Dezhi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dezhi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dezhi Li. The network helps show where Dezhi Li may publish in the future.

Co-authorship network of co-authors of Dezhi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Dezhi Li. A scholar is included among the top collaborators of Dezhi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dezhi Li. Dezhi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Li, Dezhi, et al.. (2022). Silencing of TMED5 inhibits proliferation, migration and invasion, and enhances apoptosis of hepatocellular carcinoma cells. Advances in Clinical and Experimental Medicine. 32(6). 677–688. 3 indexed citations
4.
Li, Dezhi, et al.. (2022). Objective to identify and verify the regulatory mechanism of DTNBP1 as a prognostic marker for hepatocellular carcinoma. Scientific Reports. 12(1). 211–211. 4 indexed citations
5.
Zheng, Wei, et al.. (2022). Anti-aging effect of β-carotene through regulating the KAT7-P15 signaling axis, inflammation and oxidative stress process. Cellular & Molecular Biology Letters. 27(1). 86–86. 30 indexed citations
6.
Huang, Zhiqiang, et al.. (2022). The gut microbiome in human health and disease—Where are we and where are we going? A bibliometric analysis. Frontiers in Microbiology. 13. 1018594–1018594. 33 indexed citations
8.
Chen, Lin, et al.. (2021). The Effect of A2E on the Uptake and Release of Calcium in the Lysosomes and Mitochondria of Human RPE Cells Exposed to Blue Light. Journal of Ophthalmology. 2021. 1–10. 6 indexed citations
9.
Zheng, Wei, Yaqin Li, Yanwei Xu, et al.. (2021). Uridine alleviates carbon tetrachloride‐induced liver fibrosis by regulating the activity of liver‐related cells. Journal of Cellular and Molecular Medicine. 26(3). 840–854. 31 indexed citations
10.
Li, Dezhi, et al.. (2021). miR-498 inhibits autophagy and M2-like polarization of tumor-associated macrophages in esophageal cancer via MDM2/ATF3. Epigenomics. 13(13). 1013–1030. 20 indexed citations
11.
Liu, Ke, Huimin Gong, Dezhi Li, et al.. (2020). Death by histone deacetylase inhibitor quisinostat in tongue squamous cell carcinoma via apoptosis, pyroptosis, and ferroptosis. Toxicology and Applied Pharmacology. 410. 115363–115363. 49 indexed citations
12.
Li, Dezhi, Xinyuan Liu, Sun Yu, et al.. (2020). orf6 and orf10 in Prophage phiv142-3 Enhance the Iron-Acquisition Ability and Resistance of Avian Pathogenic Escherichia coli Strain DE142 to Serum. Frontiers in Veterinary Science. 7. 588708–588708. 6 indexed citations
13.
Li, Dezhi, et al.. (2020). <p>Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma</p>. Cancer Management and Research. Volume 12. 4923–4935. 16 indexed citations
14.
Liu, Ke, Duo Li, Dongyang Xu, et al.. (2019). Ginkgolic Acid, a SUMO-1 Inhibitor, Inhibits the Progression of Oral Squamous Cell Carcinoma by Alleviating SUMOylation of SMAD4. Molecular Therapy — Oncolytics. 16. 86–99. 33 indexed citations
15.
Tang, Fang, Dezhi Li, Song Gao, et al.. (2019). Comparative genomic analysis of 127 Escherichia coli strains isolated from domestic animals with diarrhea in China. BMC Genomics. 20(1). 212–212. 18 indexed citations
16.
Xie, Qingqing, Qi Lin, Dezhi Li, & Jianming Chen. (2017). Imatinib induces autophagy via upregulating XIAP in GIST882 cells. Biochemical and Biophysical Research Communications. 488(4). 584–589. 11 indexed citations
17.
Sun, Jianguo, Rongxia Liao, Shaoxiang Zhang, et al.. (2011). Role of Inhibitor of Apoptosis Protein Livin in Radiation Resistance in Nonsmall Cell Lung Cancer. Cancer Biotherapy and Radiopharmaceuticals. 26(5). 585–592. 19 indexed citations
18.
Wu, Dongmei, Dan Zhao, Dezhi Li, et al.. (2011). Maslinic acid induces apoptosis in salivary gland adenoid cystic carcinoma cells by Ca2+-evoked p38 signaling pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 383(3). 321–330. 29 indexed citations
19.
Sun, Jianguo, Li Deng, Yu‐zhong Duan, et al.. (2011). Inhibitory effect of endostatin combined with paclitaxel-cisplatin on breast cancer in xenograft-bearing mice. Experimental and Therapeutic Medicine. 3(2). 159–164. 8 indexed citations
20.
Chu, Wenfeng, Dongmei Wu, Wei Liu, et al.. (2009). Sulforaphane induces G2–M arrest and apoptosis in high metastasis cell line of salivary gland adenoid cystic carcinoma. Oral Oncology. 45(11). 998–1004. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026